SR 400 Express Lanes Construction Newsletter, April 2026

The Georgia Department of Transportation published an April 2026 construction newsletter for the SR 400 Express Lanes project. The document provided is a newsletter archive page containing primarily navigation, subscription, and language-translation elements. No substantive project updates, construction milestones, traffic advisories, or regulatory information were present in the source content provided.

Pike County Bridge Replacement Seeks Public Input

The Georgia Department of Transportation is seeking public input on the Pike County Bridge Replacement project. This consultation invites community members to review and comment on the proposed bridge work before final decisions are made. The project aims to replace aging infrastructure while providing opportunities for local stakeholder feedback.

Georgia DOT Awards $96.5M for 24 Transportation Projects

Georgia DOT awarded 24 transportation contracts totaling approximately $96.5 million at the March State Transportation Board meeting. Contracts were awarded to lowest qualified bidders on April 2, 2026. The largest construction project ($20.5M) covers SR 21 grade separation at Norfolk Southern Railroad crossing in Jenkins County. Six construction projects total $46.2M (48% of funds), 13 resurfacing projects total $44.5M (46%), and 4 safety projects total $5.8M (6%). Fiscal Year 2026 total construction contracts now stand at approximately $2.09 billion.

Infrastructure Projects Awarded in East-Central Georgia

The Georgia Department of Transportation announces infrastructure projects awarded in East-Central Georgia. The newsletter serves as an informational bulletin listing recent contract awards by the agency. No specific project names, dollar amounts, or deadlines are detailed in the available content.

Phase 2 StromaForte vs HA Knee OA Study

NIH ClinicalTrials.gov registered Phase 2 study NCT07542808 evaluating human allogeneic bone-marrow-derived mesenchymal stromal cell product StromaForte against hyaluronic acid for treatment of knee osteoarthritis. The open-label, double-treatment group trial is listed with an anticipated completion date of April 21, 2026.

NCT07542340: Osteopathic Intervention Migraine Clinical Trial

The National Institutes of Health registered clinical trial NCT07542340, a randomized study evaluating the effect of osteopathic intervention on migraine. The trial will enroll participants experiencing migraine and assign them to receive either an osteopathic intervention protocol or placebo technique. The study investigates whether manual therapy techniques targeting the upper neck may reduce migraine pain intensity and frequency.

Phase 4 TAF vs TDF Pregnancy Study, NCT07542951

The NIH has registered a Phase 4 clinical trial (NCT07542951) comparing Tenofovir alafenamide (TAF) versus Tenofovir disoproxil fumarate (TDF) for antiviral therapy in pregnant women with chronic hepatitis B. The study will evaluate HBV mother-to-child transmission rates, birth defect incidence, adverse events, and newborn growth and development. Participants will receive daily drug treatment throughout pregnancy with clinic visits every 4 weeks during pregnancy and every 12 weeks postpartum.

Phase 2 Randomized Trial Comparing Three Pulpotomy Agents in 165 Children

The NIH ClinicalTrials.gov registry has published a Phase 2 randomized controlled trial (NCT07541976) comparing three pulpotomy agents for primary molar procedures in children. The 18-month study will enroll 165 healthy children aged 5-8 years, randomly assigned to receive either Mineral Trioxide Aggregate (MTA), Ferric Sulfate, or Chitosan Hydrogel treatment. The trial aims to determine which material maintains treated tooth health for the longest duration.

Confocal Microscopy Detects Prostate Cancer Margins During Surgery

NIH has registered clinical trial NCT07541911, evaluating the LaserSAFE confocal microscopy technique for detecting positive cancer margins during radical prostatectomy. The single-arm study will assess whether real-time intraoperative imaging can improve surgeons' nerve-preservation decision-making compared to standard practice. Participants undergo standard prostate surgery with initial nerve-sparing intent, followed by LaserSAFE analysis of the removed prostate, with additional tissue excision guided by the technique.

HLX316 Phase I Study, Advanced/Metastatic Solid Tumors

NCT07541534: A first-in-human, open-label Phase I clinical study of HLX316 in participants with advanced or metastatic solid tumors, registered with ClinicalTrials.gov. The study comprises a Phase Ia dose-escalation part and a Phase Ib dose-expansion part, focusing on platinum-resistant ovarian cancer, primary peritoneal cancer, and fallopian tube cancer. The study evaluates safety, tolerability, pharmacokinetic characteristics, and preliminary antitumor activity.

Laser Acupuncture for Cardiorenal Metabolic Syndrome - NCT07543211, Taiwan

NIH registered NCT07543211 on ClinicalTrials.gov, an observational study evaluating laser acupuncture effects on arterial stiffness in 35 patients with cardiorenal metabolic syndrome (CRMS) at a Chinese medicine clinic in Taiwan. The single-group pre-post design applies low-level laser therapy at bilateral BL40 acupoints over 12 weeks, measuring pulse wave velocity as the primary outcome.

11 for Health Pakistan Study, 254 Schoolchildren

NIH ClinicalTrials.gov registered study NCT07542574, a randomized controlled trial examining the '11 for Health' school-based football intervention among 254 fifth- and sixth-grade students (126 boys, 128 girls) across five schools in Islamabad, Pakistan. Researchers allocated participants to an 11-week intervention group, a 5-week intervention group, and a control group, assessing cardiorespiratory health, physical fitness, health knowledge, and well-being before and after the intervention.

Phase 1 MDMA Therapy for Bulimia Nervosa

The NIH ClinicalTrials.gov registry has registered a new Phase 1 clinical study (NCT07542145) evaluating MDMA Assisted Therapy (MDMA-AT) for Bulimia Nervosa. The 10-week trial will assign participants to MDMA-AT, MDMA-AT-BN, or Standard Treatment groups, with three experimental dosing sessions followed by integrative sessions, 12 psychotherapy sessions, and a 6-month follow-up.

NCT07541612 NIRS Spinal Cord Ischemia Observational Study

ClinicalTrials.gov registered observational study NCT07541612 evaluating near-infrared spectroscopy (NIRS) monitoring of paraspinal muscles as a surrogate marker for spinal cord perfusion in patients undergoing major noncardiac aortic surgery. The prospective study will enroll adult patients undergoing major surgery requiring advanced hemodynamic monitoring, placing NIRS sensors over paraspinal regions to continuously record regional tissue oxygen saturation values throughout the perioperative period.

Move to Universal Credit Statistics, July 2022 to March 2026

The Department for Work and Pensions has announced the release of official statistics covering managed migration notices sent to individuals invited to claim Universal Credit. The statistics, covering the period July 2022 to end March 2026, are scheduled for release on 12 May 2026 at 9:30am. This is a routine statistical announcement providing data on welfare benefit transition notices and does not create any new compliance obligations.

Adult Skills Fund Devolved Grant Determination Letters 2026 to 2027

The Department for Work and Pensions has issued grant determination letters to 13 Strategic Authorities in England confirming Adult Skills Fund (ASF) and Free Courses for Jobs funding for the 2026 to 2027 financial year (1 April 2026 to 31 March 2027). The letters cover ASF grant payments, Skills Bootcamps payments, and Free Courses for Jobs funding, all transferred under section 31 of the Local Government Act 2003.

Emma Douglas Appointed Chair of The Pensions Regulator

Emma Douglas has been appointed Chair of The Pensions Regulator (TPR) for a five-year term commencing 1 July 2026, succeeding interim Chair Kirstin Baker. Douglas brings over 25 years of experience in investment management and pensions, having served as Wealth Policy Director at AVIVA and Chair of Pensions UK. Her appointment coincides with what the government describes as the most significant transformation of the UK pensions landscape in a generation.

Four New Forestry Commission Commissioners Appointed by Royal Warrant

By Royal Warrant, His Majesty King Charles III has appointed four new Commissioners to the Forestry Commission. Rebecca Heaton and Mike Kapur were appointed for four-year terms while Pamela Abbott and John Varley were appointed for three-year terms. All four appointments commenced on 1 April 2026 and were made in accordance with the Governance Code on Public Appointments.

New EU Pet Travel Rules Take Effect for GB Residents

From 22 April 2026, new EU rules on non-commercial movement of pet dogs, cats, and ferrets from Great Britain take effect. GB residents can no longer use EU pet passports for entry to the EU—instead, they must obtain an Animal Health Certificate (AHC) from a UK official veterinarian for each trip, though the certificate remains valid for up to six months for onward EU travel and re-entry to GB. Key changes include a five-pet limit per private vehicle (previously five per person) and requirements for written owner permission when someone else travels with the pet, with the pet required to travel within five days of the owner.

Precision Bred Soy Bean Plant Release Notice PBR/26/004 in England

DEFRA has published notice PBR/26/004 of intention to release a precision bred soy bean plant in England under schedule 1 of the Genetic Technology (Precision Breeding) Regulations 2025. The release is authorised on or after 6 May 2026. Interested parties may contact the DEFRA precision breeding team at pb-regulation@defra.gov.uk for further information.

EPR Packaging Payment Calculations 2026 to 2027

DEFRA and PackUK have published methodology and procedure for calculating extended producer responsibility payments to local authorities for 2026 to 2027 (year 2). The guidance includes methodology documentation plus separate payment values documents for England, Scotland, Northern Ireland, and Wales. Worked examples based on the local authority costs and performance model are also referenced. This guidance does not impose new compliance obligations but explains how existing EPR payment calculations apply for year 2.

Risk Assessment: Equine Infectious Anaemia Virus Introduction to Great Britain from EU and EFTA Member States

DEFRA published a qualitative risk assessment on 21 April 2026 evaluating the likelihood of equine infectious anaemia virus (EIAV) introduction into Great Britain from EU and EFTA member states. The assessment covers England, Scotland and Wales, considering both the probability of virus entry and subsequent exposure risk for domestic equids including horses and donkeys. It also examines the potential consequences of an outbreak should introduction occur.

Codifies User Fee Exemption and Non-Display Usage Definition in Fee Schedule

Cboe EDGX Exchange has filed a proposed rule change to codify two existing practices within its Fee Schedule: (1) a User Fee exemption for Controlled Distributors accessing market data solely for Permitted Purposes (software development, QA, testing, sales support for redistribution, or technical monitoring), and (2) an amended definition of 'Non-Display Usage' to capture machine or automated access not solely in support of display for natural persons, explicitly encompassing Large Language Model usage. The prior Non-Display Usage definition (access without display by a natural person) is being updated to address evolving automated technology. The filing consolidates these definitions from the Cboe Global Markets North American Data Policies into the Exchange's Fee Schedule for transparency.

2026 DVLA Report Environment Wales Act 2016 Schedule 6 Biodiversity Duty

DVLA has published its 2026 biodiversity duty report under the Environment (Wales) Act 2016 Schedule 6, setting out how it protects habitats and species, manages invasive plants, and supports nature recovery across its Morriston and industrial sites in Swansea. The report fulfills DVLA's statutory biodiversity reporting obligation and is available on GOV.UK. No compliance obligations or enforcement actions are imposed on external parties.

House FY27 Agriculture/FDA Bill Markup

The House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies is scheduled to markup the Fiscal Year 2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Bill on April 23, 2026 at 9:00 AM in H-140 Capitol, Washington, D.C. The markup is a congressional committee session where legislators debate, amend, and vote on the appropriations bill before it advances to the full House.

House Panel to Markup FY27 National Security, Dept. of State Bill

The House Appropriations Subcommittee on National Security, Department of State, and Related Programs will hold a markup session on the Fiscal Year 2027 National Security, Department of State, and Related Programs Bill on April 23, 2026 at 8:00 AM Local Time in H-140 Capitol, Washington, D.C. Supporting documentation is available via PDF on the House Appropriations Committee website. This markup represents a committee-level vote to advance the appropriations bill before full House consideration.

Council Implementing Regulation (EU) 2026/885 of 21 April 2026 Amending Russia Restrictive Measures

The Council of the European Union published Council Implementing Regulation (EU) 2026/885 on 21 April 2026, amending Regulation (EU) 2024/2642 concerning restrictive measures targeting Russia's destabilising activities. This implementing regulation introduces updated restrictions aligned with the ongoing Russia sanctions regime. Entities operating within the EU that are subject to financial sanctions obligations should review their compliance programmes to account for any new designations or measures incorporated through this implementation.

Preaxia Health Care Files 8-K Disclosing Non-Reliance on Q3 2025 Financials

Preaxia Health Care Payment Systems Inc. (Nevada, SEC File No. 000-52365) filed an 8-K on April 21, 2026 disclosing that management identified material errors in Q3 2025 financial statements (three months ended August 31, 2025) related to stock award valuation, timing, and lack of option disclosures. The company's management has concluded that these previously released financial statements should no longer be relied upon. The company will file amended Form 10-Q quarterly reports to correct the errors, which are expected to be material. Management also assessed internal controls and identified a material weakness in financial reporting, resulting in disclosure controls and procedures that are not effective.

Radio Frequency Surgical Instrument - US12605219B2

USPTO granted US Patent 12,605,219 B2 to Kaneka Corporation for a radio frequency surgical instrument. The invention includes a tubular body, a metal wire with exposed and interior portions, and a fixture with a tapered first segment having variable radial cross-sections. The patent contains 19 claims and was filed on January 19, 2021 under application number 17800832.

Surgical Space Object Flow Monitoring, Stanford University

The USPTO granted US Patent 12605223B2 to The Board of Trustees of the Leland Stanford Junior University on April 21, 2026. The patent covers a method for monitoring object flow within a surgical space, specifically tracking needle consumption through image analysis. The invention uses computer vision to detect and log sterile packaged needles entering a surgical inventory field and tracks needle deployment during surgery.

CAMTOMSAM AB Radiation Therapy Positioning Marker Patent Grant

USPTO granted Patent US12605226B2 to CAMTOMSAM AB for a radiation therapy, microwave therapy, cryosurgery, or ultrasound therapy reference positioning marker adapted for implantation via hollow injection needle. The marker features alternating first and second segments with varying cross-sections designed to maintain linear alignment during tissue insertion when encountering resistance.

Flushing Improvements for Robotic Surgical Tool Cleaning

USPTO granted patent US12605220B2 to CILAG GMBH INTERNATIONAL for a robotic surgical tool with improved cleaning features. The patent covers a drive housing divided by a plate, an injection port for cleaning fluid, and a diverter with a ramp to direct fluid to the upper portion of the drive housing.

Surgical Equipment Holder Dock, Patent US12605227B2

USPTO granted patent US12605227B2 to LSI Solutions, Inc. on April 21, 2026. The patent covers a dock for a surgical equipment holder featuring a base with central arm mount and clamping jaw, a central docking arm, a ball cup, and a central attachment nut with an extendable moment arm. Six claims were allowed under CPC classifications A61B 90/50 and A61B 90/57, covering the mechanical docking assembly for surgical arms and rails.

MicroVention Patent for Intravascular Sensor Devices

The USPTO granted Patent US12605222B2 to MicroVention, Inc. on April 21, 2026. The patent covers medical devices with sensing characteristics for intravascular treatment sites, including occlusion devices, clot retrieval systems, and stents equipped with pressure and/or length sensors. The patent contains 20 claims and was filed on February 29, 2024 under Application No. 18592162.

EPA Region 1 Superfund Groundwater OU1 Annual Report Oct 2014-Sep 2015

EPA Region 1 published its Operable Unit 1 (OU1) annual report covering groundwater remediation activities from October 2014 through September 2015. The document is filed under docket EPA-R01-SFUND-2026-0430. The source content consists solely of a navigation page with a PDF download link; no substantive regulatory text, obligations, or deadlines are present in the provided content.

Groundwater Remediation Report, Oct 2019-Sep 2020

EPA published a groundwater remediation report covering activities from October 1, 2019 through September 30, 2020. The document summarizes cleanup progress across affected sites but contains no new regulatory requirements or enforcement obligations.

Baird McGuire OU1 ROD Amendment Proposed Plan

EPA Region 1 is proposing an amendment to the Record of Decision (ROD) for Operable Unit 1 (OU1) at the Baird McGuire Superfund site. The proposed plan amendment modifies the previously selected cleanup approach and is subject to a 30-day public comment period. The EPA is accepting written comments on the proposed amendment through April 30, 2026.

EPA Guidance on Cost Estimates During Feasibility Studies

The Environmental Protection Agency issued guidance titled 'EPA Guidance on Cost Estimates During Feasibility Studies.' The document provides direction on preparing cost estimates during the feasibility study phase of environmental remediation projects under the Superfund program. The source contains only a download link with no substantive text.

EPA Issues Institutional Control Notice for Superfund Sites

EPA has issued a notice regarding institutional controls at Superfund sites. The notice addresses requirements for maintaining and monitoring institutional controls at contaminated properties cleaned up under the Superfund program. Institutional controls are non-engineering measures such as deed restrictions, easements, or zoning requirements used to limit land or resource use at contaminated sites.

EPA QA Evaluation Memo, Apr 21

The EPA Region 1 (New England) Quality Assurance Division issued an evaluation memo on April 21, 2026. The document is an internal QA review associated with Superfund program activities under document ID EPA-R01-SFUND-2026-0430-0054. No specific compliance obligations, deadlines, or penalties are stated in the available source content.

Superfund Site Institutional Control Notice

EPA Region 1 published a notice regarding institutional controls at a Superfund site. Institutional controls are legal restrictions on property use that protect human health and the environment when complete cleanup is not feasible. The notice was filed to the public docket and is available for download as a PDF document.

NAUL Institutional Control Superfund Site 19-006-00-0

EPA Region 1 posted a document related to institutional controls at the NAUL Superfund site (19-006-00-0). The filing is available for download via regulations.gov. No substantive text content was provided in the source.

Institutional Control Notice, Superfund Site 25-129-02-0

EPA Region 1 issued an Institutional Control Notice for Superfund Site 25-129-02-0. Institutional controls establish legally enforceable restrictions on land or resource use at Superfund cleanup sites to protect human health and the environment from residual contamination. The notice provides official documentation of these controls and any associated requirements for the affected property.

EPA Evaluates Future Reuse for Remediated Sites

EPA Region 1 posted a document related to evaluating future reuse options for remediated sites under the Superfund program. The document is available as a PDF download via regulations.gov. No substantive text content, obligations, or deadlines are provided in the listing.

EPA Region 1 FAQ on Superfund Remedial Action Procedures

EPA Region 1 published a Frequently Asked Questions document addressing Superfund remedial action procedures. The FAQ provides guidance on cleanup processes at contaminated sites managed under the Superfund program. No new compliance obligations, deadlines, or penalties are established by this informational document.

EPA Guidance for Upper Confidence Limits at Hazardous Waste Sites

EPA has published guidance on applying upper confidence limits (UCL) at hazardous waste sites. The document, issued by EPA Region 1, addresses statistical methods for estimating upper bounds of contaminant concentrations when assessing cleanup actions. Site owners, contractors, and environmental consultants involved in Superfund and hazardous waste remediation should review the guidance to ensure statistical analyses meet EPA expectations.

BigShot Awards Honor 162 Wisconsin Providers for Vaccinations

The Wisconsin Department of Health Services announced its tenth annual BigShot awardees, recognizing 162 Wisconsin healthcare providers for achieving high childhood vaccination rates. Providers were honored in four categories based on benchmarks for DTaP, poliovirus, MMR, Hib, HepB, varicella, PCV, Tdap, meningococcal, and HPV vaccines. DHS noted that childhood vaccinations are declining in Wisconsin amid a resurgence of vaccine-preventable diseases such as measles.

D&M Electric LLC EV Charging Station Certification Application

D&M Electric LLC filed an application for certification to install, maintain, or repair electric vehicle charging station facilities under Section 16-128A of the Illinois Public Utilities Act on April 21, 2026. The Illinois Commerce Commission docket P2026-0358 is currently in Initial status with Administrative Law Judge Action Pending. This is a routine certification filing for EV charging infrastructure installers seeking authority to operate in Illinois.

ComEd Rider Distributed System Extensions Rehearing Petition

Commonwealth Edison Company has filed a rehearing petition in Illinois Commerce Commission docket P2025-0679 seeking revisions to Rider Distributed System Extensions, a tariff proposal originally filed June 23, 2025. The case is assigned to Administrative Law Judges Matthew Locke and Caitlin Groh. The initial suspension period ends November 19, 2025, with a resuspension period ending May 19, 2026. Commission action on the rehearing petition remains pending.

Onbulb LED Inc EV Charging Station Certification

Onbulb LED Inc filed an application on April 21, 2026, seeking certification from the Illinois Commerce Commission to install, maintain, or repair electric vehicle charging station facilities under Section 16-128A of the Public Utilities Act. The case (P2026-0360) is classified as a Certificate for Installers request for new authority and is currently in Initial status with Administrative Law Judge action pending. This is a procedural filing initiating a regulatory review process; no decision has been issued.